Mafalda Oliveira
@moliveira_md
Medical oncologist @Vallhebron| Head @_SOLTI Group | Breast cancer | Drug development | orcid.org/0000-0001-9152…
ID: 1395607160
http://www.vhio.net 01-05-2013 21:23:00
459 Tweet
879 Takipçi
337 Takip Edilen
What is the impact of immune checkpoint inhibitors in the outcome of patients with early breast cancer? Check out this huge work led by Guillermo Villacampa and Tomás Pascual Treatment tailoring is paramount to improve patient care! ESMO - Eur. Oncology OncoAlert Vall d’Hebron Institute of Oncology (VHIO) ASCO